V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260013023 | 260008103 | 1.53 | 85 | Disease modification (D) | 2013-08-31 | 2013-09-04 | Bendamustine+Rituximab(Sub Courses) | N | N | 260025214 | BENDAMUSTINE + RITUXIMAB |
| 260013024 | 260008103 | 1.77 | 70.7 | Disease modification (D) | 2014-01-04 | 2014-03-12 | BENDAMUSTINE + RITUXIMAB | N | N | 260025214 | BENDAMUSTINE + RITUXIMAB |
| 260013025 | 260016601 | 1.8 | 78.6 | Palliative (P) | 2018-08-31 | 2018-09-02 | Bendamustine+Rituximab(Sub Courses) | N | N | 260025216 | BENDAMUSTINE + RITUXIMAB |
| 260013026 | 260013798 | 1.9 | 82.7 | Curative (C) | 2015-09-01 | 2015-09-02 | BEP 5 Day | null | N | 260025218 | BEP |
| 260013027 | 260008109 | 1.79 | null | Curative (C) | 2013-06-09 | 2013-06-20 | BEP 5 Day | 02 | N | 260025223 | BEP |
| 260013028 | 260008109 | 1.92 | 76.2 | Disease modification (D) | 2018-03-31 | 2018-04-08 | BENDAMUSTINE + RITUXIMAB | N | N | 260025223 | BENDAMUSTINE + RITUXIMAB |
| 260013029 | 260008109 | 1.76 | null | Curative (C) | 2015-01-16 | 2015-01-21 | BEP 3 day | N | N | 260025223 | BEP |
| 260013030 | 260018665 | null | null | null | 2016-12-22 | 2016-12-22 | BEP 5 Day | 02 | N | 260025232 | BEP |
| 260013031 | 260008110 | 1.7 | 74.4 | Not known (9) | 2016-09-08 | 2016-10-06 | BEP 5 Day | 2 | N | 260025232 | BEP |
| 260013032 | 260008111 | 1.87 | 61.8 | Disease modification (D) | 2016-06-19 | 2016-07-03 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260025234 | BENDAMUSTINE + RITUXIMAB |
| 260013033 | 260008111 | 1.7 | 63.95 | Palliative (P) | 2017-01-10 | 2017-02-21 | Bendamustine+Rituximab(Sub Courses) | 02 | N | 260025234 | BENDAMUSTINE + RITUXIMAB |
| 260013034 | 260008111 | 1.74 | 78.1 | Palliative (P) | 2015-05-06 | 2015-09-11 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260025234 | BENDAMUSTINE + RITUXIMAB |
| 260013035 | 260008111 | 1.79 | 94 | Curative (C) | 2017-01-28 | 2017-01-28 | BENDAMUSTINE + RITUXIMAB | N | N | 260025234 | BENDAMUSTINE + RITUXIMAB |
| 260013036 | 260019382 | 1.87 | 67.5 | Palliative (P) | 2016-10-19 | 2016-10-25 | Bendamustine+Rituximab(Sub Courses) | 2 | N | 260025240 | BENDAMUSTINE + RITUXIMAB |
| 260013037 | 260008112 | 0 | 69.6 | Curative (C) | 2014-03-17 | 2014-03-24 | BEP 5 Day | N | N | 260025240 | BEP |
| 260013038 | 260008112 | 1.77 | 42.5 | null | 2017-06-28 | 2017-08-18 | BEP 3 day | N | N | 260025240 | BEP |
| 260013039 | 260008112 | 1.81 | 74.4 | Palliative (P) | 2015-11-13 | 2015-11-16 | BEP 3 day | 02 | N | 260025240 | BEP |
| 260013040 | 260008113 | 1.85 | 75 | Curative (C) | 2015-03-02 | 2015-05-06 | BEP 3 day | 02 | N | 260025256 | BEP |
| 260013041 | 260008113 | 1.67 | 69 | Disease modification (D) | 2015-03-29 | 2015-04-13 | Bendamustine+Rituximab(Sub Courses) | N | N | 260025256 | BENDAMUSTINE + RITUXIMAB |
| 260013042 | 260008114 | 1.63 | 71 | Disease modification (D) | 2017-01-26 | 2017-01-30 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260025259 | BENDAMUSTINE + RITUXIMAB |
| 260013043 | 260008115 | 1.81 | 84 | Disease modification (D) | 2017-02-15 | 2017-02-20 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260025261 | BENDAMUSTINE + RITUXIMAB |
| 260013044 | 260008115 | 1.57 | 60.1 | Palliative (P) | 2016-07-28 | 2016-09-12 | BENDAMUSTINE + RITUXIMAB | N | N | 260025261 | BENDAMUSTINE + RITUXIMAB |
| 260013045 | 260008117 | 1.8 | 84 | Disease modification (D) | 2015-09-23 | 2015-09-23 | BENDAMUSTINE + RITUXIMAB | 2 | N | 260025263 | BENDAMUSTINE + RITUXIMAB |
| 260013046 | 260013808 | 1.57 | 79.8 | Curative (C) | null | 2015-09-17 | BEP 5 Day | N | N | 260025266 | BEP |
| 260013047 | 260008121 | 1.88 | 94.2 | Curative (C) | 2013-08-20 | 2013-08-27 | BENDAMUSTINE + RITUXIMAB | N | N | 260025268 | BENDAMUSTINE + RITUXIMAB |
| 260013048 | 260013809 | 1.58 | 76.2 | Palliative (P) | 2014-05-06 | 2014-06-24 | Bendamustine+Rituximab(Sub Courses) | N | N | 260025268 | BENDAMUSTINE + RITUXIMAB |
| 260013049 | 260008122 | 1.84 | 54 | Disease modification (D) | 2016-07-26 | 2016-08-21 | BEP 3 day | 2 | N | 260025271 | BEP |
| 260013050 | 260008122 | 1.71 | null | Palliative (P) | 2016-02-10 | 2016-02-29 | Bendamustine+Rituximab(Sub Courses) | 02 | N | 260025271 | BENDAMUSTINE + RITUXIMAB |
| 260013051 | 260008122 | 1.6 | 119 | Curative (C) | 2014-07-22 | 2014-08-12 | BEP 5 Day | N | N | 260025271 | BEP |
| 260013052 | 260008123 | 1.72 | 92.1 | Palliative (P) | 2014-04-04 | 2014-04-13 | Bendamustine+Rituximab(Sub Courses) | N | N | 260025278 | BENDAMUSTINE + RITUXIMAB |
| 260013053 | 260013811 | 1.7 | 80.1 | null | 2016-08-20 | 2016-08-25 | BEP 5 Day | 02 | N | 260025278 | BEP |
| 260013056 | 260008127 | null | 75.2 | null | 2013-05-14 | 2013-05-21 | BEP 3 day | 02 | N | 260025284 | BEP |
| 260013057 | 260008127 | 1.78 | 86.9 | Curative (C) | 2016-10-15 | 2016-11-14 | BEP 3 day | 02 | N | 260025284 | BEP |
| 260013058 | 260008128 | null | 89.15 | Adjuvant (A) | 2014-05-29 | 2014-05-29 | BEP 3 day | N | N | 260025287 | BEP |
| 260013059 | 260008128 | 1.72 | null | null | 2016-01-26 | 2016-02-14 | BEP 5 Day | N | null | 260025287 | BEP |
| 260013060 | 260008128 | 1.83 | 87.4 | Palliative (P) | 2013-03-21 | 2013-04-22 | BEP 5 Day | N | N | 260025287 | BEP |
| 260013061 | 260017990 | null | null | null | 2016-02-01 | 2016-02-09 | BENDAMUSTINE + RITUXIMAB | N | N | 260025290 | BENDAMUSTINE + RITUXIMAB |
| 260013062 | 260008129 | 1.94 | 84 | Palliative (P) | 2016-07-02 | 2016-07-25 | BENDAMUSTINE + RITUXIMAB | N | N | 260025291 | BENDAMUSTINE + RITUXIMAB |
| 260013063 | 260016616 | 1.45 | 73 | Curative (C) | 2014-06-11 | 2014-08-06 | BEP 3 day | 02 | N | 260025302 | BEP |
| 260013064 | 260013817 | 1.74 | 76.2 | Disease modification (D) | null | 2015-06-12 | Bendamustine+Rituximab(Sub Courses) | N | N | 260025304 | BENDAMUSTINE + RITUXIMAB |
| 260013065 | 260008132 | 1.65 | 85 | Palliative (P) | 2018-08-17 | 2018-09-02 | BENDAMUSTINE + RITUXIMAB | N | Y | 260025306 | BENDAMUSTINE + RITUXIMAB |
| 260013066 | 260008132 | 1.8 | 87 | Palliative (P) | 2016-11-10 | 2016-12-07 | Bendamustine+Rituximab(Sub Courses) | N | N | 260025306 | BENDAMUSTINE + RITUXIMAB |
| 260013067 | 260016617 | null | 67.7 | null | 2017-05-31 | 2017-06-08 | BEP 3 day | N | null | 260025314 | BEP |
| 260013068 | 260008136 | 1.83 | 80.3 | Disease modification (D) | 2015-06-07 | 2015-06-10 | BEP 5 Day | 02 | N | 260025317 | BEP |
| 260013069 | 260013820 | 1.82 | 89.5 | Curative (C) | 2014-10-28 | 2014-11-03 | BEP 3 day | 02 | N | 260025318 | BEP |
| 260013070 | 260013820 | 1.64 | 95.3 | Palliative (P) | 2016-12-08 | 2016-12-09 | BENDAMUSTINE + RITUXIMAB | N | N | 260025318 | BENDAMUSTINE + RITUXIMAB |
| 260013071 | 260008137 | 1.86 | 68 | Palliative (P) | 2014-12-22 | 2015-01-24 | BEP 3 day | N | N | 260025321 | BEP |
| 260013072 | 260016619 | 1.77 | 92.7 | Not known (9) | 2015-11-30 | 2015-12-21 | BEP 3 day | N | N | 260025324 | BEP |
| 260013073 | 260008138 | null | null | Palliative (P) | 2015-03-19 | 2015-03-24 | BENDAMUSTINE + RITUXIMAB | 2 | N | 260025324 | BENDAMUSTINE + RITUXIMAB |
| 260013074 | 260008139 | 2 | 131.2 | Palliative (P) | 2014-11-11 | 2014-11-29 | BENDAMUSTINE + RITUXIMAB | N | N | 260025326 | BENDAMUSTINE + RITUXIMAB |